Application YC di AesculaTech
AesculaTech ha partecipato a Y Combinator nel batch Winter 2018 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Winter 2018
- Settore
- HealthcareMedical Devices
- Dimensione team
- 6
- Stato
- Active
- Lanciata
- 2017
Founder
Niki BayatFounder/CEO
Cosa fa AesculaTech
AesculaTech believes in building better lives through smart chemistry. We design custom smart materials for a range of biomedical, commercial, and industrial applications. Our platform technology, AesculaGel offers adaptive response to a wide range of stimuli and can be tailor-made for biocompatibility, material strength, and a range of other attributes. Founded by one of MIT's 35 under 35 Innovators, AesculaTech is the shared vision of scientists, engineers, and medical experts. Our cornerstone product, Humidifeye, is an ophthalmic platform to treat dry eye disease. Dry eye affects more than 25 million Americans and the global treatment market is projected higher than $6 Billion within the next decade. Our thermally responsive, form-fitting materials are suitable for sustained yet reversible occlusion across a range of treatment times. In contrast to existing technologies, our product will not extrude, or cause discomfort as it adapts to patients. Though Humidifeye is not yet FDA approved, expect to hear about it soon! In coordination with partners across several sectors, we have a variety of groundbreaking technologies in the works that live up to our vision. This work has already been recognized. AesculaTech was named a Rosenman Innovator, received a National Science Foundation I-Corps grant, was a finalist in the 2019 Octane High Tech Awards, and is a graduate of both the Y Combinator and TMCx accelerator programs. In short, Y-Combinator was only the beginning.
Application YC di AesculaTech, ricostruita
Domanda per Y Combinator
AesculaTech, batch Winter 2018. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
AesculaTech
Responsive materials, better lives.
We make AesculaGel, a smart, adaptive material platform that responds to stimuli and can be tailor-made for strength and biocompatibility. Our lead product, Humidifeye, uses these materials for sustained, comfortable treatment of dry eye disease by providing thermally responsive, form-fitting occlusion that adapts to patients instead of causing discomfort or extrusion like current options.
We live in Los Angeles, CA, and we would continue to be based here after YC.
Los Angeles is our home base with access to local medical experts and manufacturing partners. Staying here keeps our team close and connected to the relevant biomedical ecosystem.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di AesculaTech?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di AesculaTech (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come AesculaTech si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva AesculaTech?
AesculaTech apparteneva al batch Winter 2018 di Y Combinator.
Chi ha fondato AesculaTech?
AesculaTech è stato fondato da Niki Bayat.
Cosa fa AesculaTech?
Responsive materials, better lives.
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di AesculaTech, e di ogni altro batch YC, è in YC Insights.
Più startup YC come AesculaTech
